Perinatal Depression Treatment and Child Development
Perinatal Depression Treatment and Child Development: A Follow-Up of the Thinking Healthy Programme
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Islamabad, Pakistan
- Human Development Research Foundation
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- children of women who were eligible to participate in the Thinking Healthy Programme
Exclusion Criteria:
- developmental disability, visual or hearing impairment
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
depressed mother/child dyad - intervention
|
|
depressed mother/child dyad - no intervention
|
|
non-depressed mother/child dyad
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Estimate of general intelligence
Time Frame: Re-enrollment visit, approximately 7 years post-intervention
|
Re-enrollment visit, approximately 7 years post-intervention
|
|
|
Measures of executive functions
Time Frame: Re-enrollment visit, approximately 7 years post-intervention
|
Working memory, cognitive flexibility, inhibitory control, and sustained attention will be measured by standard tests of cognitive functioning.
|
Re-enrollment visit, approximately 7 years post-intervention
|
|
Level of literacy and numeracy
Time Frame: Re-enrollment visit, approximately 7 years post-intervention
|
Re-enrollment visit, approximately 7 years post-intervention
|
|
|
Presence of behavioral and emotional problems (socio-emotional development)
Time Frame: Re-enrollment visit, approximately 7 years post-intervention
|
Re-enrollment visit, approximately 7 years post-intervention
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Height-for-age
Time Frame: Re-enrollment visit, approximately 7 years post-intervention
|
Re-enrollment visit, approximately 7 years post-intervention
|
|
Weight-for-age
Time Frame: Re-enrollment visit, approximately 7 years post-intervention
|
Re-enrollment visit, approximately 7 years post-intervention
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Joanna Maselko, ScD, Duke University
- Principal Investigator: Siham Sikander, PhD, Human Development Research Foundation, Pakistan
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Pro00034166
- Saving Brains #0058 (Other Grant/Funding Number: Grand Challenges Canada)
- ISRCTN65316374 (Registry Identifier: International Standard Randomised Controlled Trial Number)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.